[144] VTEX SEC Filing
VTEX Form 144 notice: The filer proposes to sell 4,500 shares of VTEX common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $18,630.00. The securities were acquired on 03/19/2019 through previously exercised stock options and were paid for in cash.
The filing shows the approximate date of sale as 09/16/2025 on the NYSE. Recent related transactions disclosed include multiple Rule 10b5-1 sales during July and August 2025 totaling 9,000 shares with gross proceeds reported for each sale.
- None.
- None.
Insights
TL;DR: Small planned insider sale and multiple recent 10b5-1 dispositions, likely routine liquidity, limited market impact.
The Form 144 indicates a proposed sale of 4,500 shares valued at $18,630.00, representing a modest volume relative to typical public float sizes. The shares were acquired via exercised options on 03/19/2019 and paid in cash, which suggests these are post-exercise disposals rather than primary issuance. The filing also documents several 10b5-1 sales in July and August 2025 totaling 9,000 shares, with gross proceeds recorded for each transaction. From a securities-analysis perspective, these disclosures are important for transparency but do not, by themselves, indicate material change in company fundamentals.
TL;DR: Disclosure complies with Rule 144; repeated 10b5-1 activity shows planned selling under trading plans.
The notice states the seller represents no undisclosed material adverse information and references reliance on Rule 10b5-1 for prior sales. The presence of multiple 10b5-1 sales suggests the disposer is using pre-established plans to address insider trading restrictions. The proposed sale date is 09/16/2025, and execution via a major broker is specified. Documentation appears procedural and aligned with regulatory requirements for reporting proposed insider sales.